Why is the US about to see a fall in the price of many drugs?

Business Matters

It's been a landmark day in the US, particularly for the millions struggling to afford vital health care medicine. But why is there about to be a fall in the price of many drugs? Rahul Tandon speaks to a health policy professor in Tennessee.

Meanwhile, as Sweden's confirmed the first case of the new Mpox variant outside Africa, we hear from Paul Chaplin, of drug manufacturer Bavaria Nordic who are the main producer of the vaccine, on whether there's enough of the vaccine to fight the disease.

We discuss the problem's facing India's economy, where issues of women in the workplace are back in the spot light after the rape and murder of a female doctor in Kolkata.

Elsewhere, are food halls being used to increase the value of surrounding offices and apartments in cities and towns globally. Devina Gupta discusses a growing trend in the US where nearly 400 are now in operation.

And we look at why the process of getting elected, which is hard work at the best of times, has become a disaster in the most unexpected way for hundreds of candidates in Australia.

Global business news, with live guests and contributions from Asia and the USA.